Inspira Technologies has engaged a consulting firm to accelerate strategic expansion and partner engagement. This move follows major achievements, including national-level strategic frameworks and clinical integration in U.S. hospitals. CEO Dagi Ben-Noon expects high-impact results to surface soon, reshaping the company’s scale. The consulting firm is evaluating configurations to boost Inspira’s global footprint and create new value in the second half of 2025. Inspira Technologies specializes in respiratory support and blood monitoring solutions, with FDA-cleared products like INSPIRA ART100 and HYLA. The company’s recent developments align with industry trends and potential partnerships.

Read more at GlobeNewswire: Inspira Activates U.S. Based Consulting Firm to Execute